BBNX vs MAS · rev $100.3M vs P/E 18, rev $7.56B
Beta Bionics, Inc. Common Stock (BBNX) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
BBNX currently screens at market cap $640.8M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the BBNX and MAS stock pages for the full models.
Not investment advice.